Conducting vaccine and drug clinical trials during disease outbreaks can be a drag. Sponsors will struggle to deliver new products against global health biothreats unless they leverage lessons learned during previous studies to influence clinical research development plans during future outbreaks.

In this Episode, I will explain how lessons learned during the 2014-15 West Africa Ebola virus outbreak can supercharge R&D during future outbreaks and deliver life-saving clinical products to patients and families faster.

*******

Hi, I'm Dr. Amos Ndhere! I am a medical doctor, Clinical Investigator, and Regulatory Affairs Specialist.

My goal is simple: Help Pharma industry leaders understand key trends, top strategies, and tools to conduct R&D in emerging markets and deliver life-changing treatments to patients faster.

*******

Do you want to deliver your clinical trial in sub-Saharan Africa safely?

Let's talk

******

Please like, share, and give me a 5-star; that'd be appreciated!👍🏻 👏 ❤️ ✍

PS - Join the conversation on social!⁠LinkedIn⁠

⁠Twitter⁠

⁠YouTube